Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 251
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07062978 | A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia® | ||
| NCT04527068 | QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer | ||
| NCT06750341 | Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol | ||
| NCT05884801 | Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors | ||
| NCT07300111 | A Study to Evaluate Efficacy and Safety of QLG1218(Daprodustat) in Chinese Hemodialysis (HD)-Dependent Subjects With Anemia Associated With Chronic Kidney Disease (CKD) | ||
| NCT07450378 | QLC7401 in Participants With Heterozygous Familial Hypercholesterolemia (HeFH) | ||
| NCT05703204 | A Study of QLF32101 in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome | ||
| NCT07079228 | A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer | ||
| NCT06041035 | A Study of QLS31905 Combination Chemotherapy as First-Line Treatment in Patients With Advanced Solid Tumors | ||
| NCT07620366 | To Evaluate the Efficacy and Safety of QL2401 in Patients With Metabolic Dysfunction-associated Steatohepatitis and Liver Fibrosis | ||
| NCT07358858 | A Food Effect Study of QLS1410 in Healthy Chinese Adults | ||
| NCT05823246 | Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma | ||
| NCT00404989 | Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. | ||
| NCT07817004 | QLM2010 Comparative Pharmacokinetic Study With 2-Minute Intravenous Administration | ||
| NCT06742138 | To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma | ||
| NCT05829616 | A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors | ||
| NCT05543343 | Staphylococcus and Neisseria Tablets in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease. | ||
| NCT06954246 | A Study of MHB088C Injection Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer | ||
| NCT05758519 | A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19 | ||
| NCT06644495 | Post-Market Surveillance Study of ALK-Positive Advanced NSCLC Participants Treated With Iruplinalkib | ||
| NCT06940336 | To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy | ||
| NCT07040826 | Lifitegrast Eye Drops in Healthy Subjects:Phase I Study | ||
| NCT07417917 | QLS12010 Capsules in Adults With Moderate to Severe Hidradenitis Suppurativa | ||
| NCT05171790 | A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid Tumors | ||
| NCT03312283 | Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD | ||
| NCT05822713 | A Comparison of the Efficacy of Amisulpride and Placebo in the Prevention of PONV in Patients at Moderate-to-high Risk of PONV. | ||
| NCT06613880 | Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia | ||
| NCT05950516 | Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes | ||
| NCT06151587 | A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children | ||
| NCT06936748 | SFRT+Sequential Hypofractionated/Conventional Fractionated RT+Iparomlimab and Tuvonralimab for Relapsed/Refractory Solid Tumors | ||
| NCT07802821 | A Study Comparing QLC5508 in Combination With QL2107 Versus Tislelizumab Plus Platinum-based Chemotherapy in Participants Wih Treatment-naïve Extensive-Stage Small Cell Lung Cancer | ||
| NCT05058118 | Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD) | ||
| NCT07327697 | A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects | ||
| NCT05802342 | A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer | ||
| NCT04632758 | Study Comparing WX-0593 to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients | ||
| NCT05860530 | Bioequivalence Study of Two Olaparib Tablets in Patients With Cancers | ||
| NCT05052567 | CEND-1 Injection (QLC12102) in Patients With Advanced Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT07004335 | Efficacy and Safety of Iparomlimab and Tuvonralimab Injection in Combination With Bevacizumab After Progression on Anti-PD-(L)1 Therapy in Advanced Melanoma: A Prospective, Single-Arm, Exploratory Clinical Study | ||
| NCT05716126 | Single Dose Mass Balance Study With [14C]Iruplinalkib (WX-0593) In Healthy Male Volunteers | ||
| NCT07735104 | The First in Human Study of QLS2319 in Healthy Subjects and Cancer Cachexia | ||
| NCT04234594 | Comparing the Pharmacokinetic and Safety of QL1203 and Vectibix® in Healthy Males. | ||
| NCT06884891 | A Phase Ⅲ Comparative Study of QL2108 to Dupixent® | ||
| NCT07612904 | Zhuochuming®-3T&E-DME Study (Treatment-naïve Patients) | ||
| NCT06500507 | A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma | ||
| NCT06614907 | A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent® | ||
| NCT07489586 | A Clinical Study of QL1207H Injection Versus Aflibercept for Neovascular Age-related Macular Degeneration | ||
| NCT06837896 | Efficacy and Safety Study of QLG1080 in Patients With Hormone-sensitive Advanced Prostate Cancer | ||
| NCT07829588 | Pharmacokinetic (PK) Study of QL1203 and Vectibix® for the Treatment of RAS Wild-type Metastatic Colorectal Cancer | ||
| NCT07632690 | QLC5508 in Participants With Metastatic Prostate Cancer | ||
| NCT07127822 | Assessing Iparomlimab and Tuvonralimab in Recurrent or Metastatic MSI-H/dMMR Gastric Cancer |
